Reduction of Atherosclerosis by the Peroxisome Proliferator-activated Receptor α Agonist Fenofibrate in Mice-Reference-Cited by-同舟云学术

Reduction of Atherosclerosis by the Peroxisome Proliferator-activated Receptor α Agonist Fenofibrate in Mice

Published:2002-12 Issue:50 Volume:277 Page:48051-48057
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Duez Hélène,Chao Yu-Sheng,Hernandez Melba,Torpier Gérard,Poulain Philippe,Mundt Steven,Mallat Ziad,Teissier Elisabeth,Burton Charlotte A.,Tedgui Alain,Fruchart Jean-Charles,Fiévet Catherine,Wright Sam D.,Staels Bart

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference46 articles.

1. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis

2. Atherosclerosis

3. Coronary Heart Disease: Reducing the Risk

4. High density lipoprotein as a protective factor against coronary heart disease

5. Mechanism of Action of Fibrates on Lipid and Lipoprotein Metabolism

Cited by 168 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An insight to treat cardiovascular diseases through phytochemicals targeting PPAR-α;Molecular and Cellular Biochemistry;2023-05-12

2. The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease;Frontiers in Cardiovascular Medicine;2023-05-02

3. Mechanosensitive Stem-Cell Genes and Klotho in Atherosclerotic Aortas: Regulating Spatially Deranged Expression Patterns Using Colchicine Regimens;Journal of Clinical Medicine;2022-10-31

4. Anti-inflammatory Drug Combination Therapy for Atherosclerosis: Colchicine and Fenofibrate;Current Medicinal Chemistry;2022-08

5. A new insight into the treatment of diabetes by means of pan PPAR agonists;Chemical Biology & Drug Design;2022-01-17